Literature DB >> 9467237

The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans.

J Scheibner1, K Lange, K Empen, E F Stange.   

Abstract

Hypersecretion of biliary cholesterol appears to be the key defect in the pathogenesis of cholesterol gallstones, and this may be due to an enhanced synthesis of cholesterol. To measure fractional syntheses of biliary and plasma cholesterol, five male and 3 female healthy humans with an intact enterohepatic circulation were infused intravenously with [1-13C]acetate for 15 h. Samples of duodenal bile and blood were taken hourly and an enteral formula diet was given. Free cholesterol mass distribution was analyzed by gas chromatography mass spectrometry. The Mass Isotopomer Distribution Analysis (MIDA) technique allowed to calculate fractional synthesis. After 6 hours of infusion, the [13C]label of the cytosolic acetate pool reached a plateau of approximately 12%. Individual fractional cholesterol synthesis is plasma and bile correlated significantly (6-15 h) and amounted to 4.2% and 5.3% after 15 h, respectively. It may be concluded from this study, that newly synthesized cholesterol is secreted into bile to a higher extent than into plasma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9467237     DOI: 10.1007/bf01617830

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  21 in total

1.  The use of C14-labeled acetate to study cholesterol metabolism in man.

Authors:  R G GOULD; G V LEROY; G T OKITA; J J KABARA; P KEEGAN; D M BERGENSTAL
Journal:  J Lab Clin Med       Date:  1955-09

2.  Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile.

Authors:  W C Duane; D B Hunninghake; M L Freeman; P A Pooler; L A Schlasner; R L Gebhard
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

3.  Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans.

Authors:  J C Mitchell; G M Logan; B G Stone; W C Duane
Journal:  J Lipid Res       Date:  1991-01       Impact factor: 5.922

4.  Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans.

Authors:  D Faix; R Neese; C Kletke; S Wolden; D Cesar; M Coutlangus; C H Shackleton; M K Hellerstein
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

5.  Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA.

Authors:  R A Neese; D Faix; C Kletke; K Wu; A C Wang; C H Shackleton; M K Hellerstein
Journal:  Am J Physiol       Date:  1993-01

6.  Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods.

Authors:  S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1969-01       Impact factor: 5.922

7.  Cholesterol and triglyceride fatty acid synthesis in apolipoprotein E2-associated hyperlipidemia.

Authors:  P J Jones; S M Dendy; J J Frohlich; C A Leitch; D A Schoeller
Journal:  Arterioscler Thromb       Date:  1992-01

8.  Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones.

Authors:  F Kern
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 9.  Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers.

Authors:  M K Hellerstein; R A Neese
Journal:  Am J Physiol       Date:  1992-11

10.  Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat.

Authors:  J Scheibner; M Fuchs; M Schiemann; G Tauber; E Hörmann; E F Stange
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.